These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16786130)

  • 21. Number of pericryptal fibroblasts correlates with density of distinct mast cell phenotypes in the crypt lamina propria of human duodenum: implications for the homeostasis of villous architecture.
    Crivellato E; Finato N; Isola M; Pandolfi M; Ribatti D; Beltrami CA
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Jun; 288(6):593-600. PubMed ID: 16652353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.
    Rahier JF; De Beauce S; Dubuquoy L; Erdual E; Colombel JF; Jouret-Mourin A; Geboes K; Desreumaux P
    Aliment Pharmacol Ther; 2011 Sep; 34(5):533-43. PubMed ID: 21736598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.
    Rijnierse A; Redegeld FA; Blokhuis BR; Van der Heijden MW; Te Velde AA; Pronk I; Hommes DW; Nijkamp FP; Koster AS; Kraneveld AD
    J Immunol; 2010 Jul; 185(1):653-9. PubMed ID: 20505143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH; Olsen JE; Jain S; Doe WF
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cells and eosinophils are involved in activation of ulcerative colitis.
    Stasikowska-Kanicka O; Danilewicz M; Głowacka A; Wągrowska-Danilewicz M
    Adv Med Sci; 2012; 57(2):230-6. PubMed ID: 22968338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
    Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
    Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy.
    Beil WJ; Pammer J
    Histochem Cell Biol; 2001 Dec; 116(6):483-93. PubMed ID: 11810190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase.
    Buckley MG; McEuen AR; Walls AF
    J Pathol; 1999 Sep; 189(1):138-43. PubMed ID: 10451500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease.
    Konno S; Iizuka M; Yukawa M; Sasaki K; Sato A; Horie Y; Nanjo H; Fukushima T; Watanabe S
    J Gastroenterol; 2004 Oct; 39(10):931-9. PubMed ID: 15549445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease.
    Farhadi A; Keshavarzian A; Fields JZ; Jakate S; Shaikh M; Banan A
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2338-43. PubMed ID: 17645464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
    Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
    J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
    Yantiss RK; Das KM; Farraye FA; Odze RD
    Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-histochemical detection of a chymase-like proteinase within bovine mucosal and connective tissue mast cells.
    Jolly S; Detilleux J; Coignoul F; Desmecht D
    J Comp Pathol; 2000; 122(2-3):155-62. PubMed ID: 10684684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells.
    Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y
    Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study.
    Balasubramanian K; Kumar S; Singh RR; Sharma U; Ahuja V; Makharia GK; Jagannathan NR
    Magn Reson Imaging; 2009 Jan; 27(1):79-86. PubMed ID: 18599242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.